February 22, 2017 at 11:10am GMT CRAIGAVON pharmaceutical firm Almac has admitted that its decision to open a factory in Dundalk was as a direct result of the UK’s vote to leave Europe. Giving ...

The test included 73 patients with recurrent disease and 142 patients with no recurrence within 5 years of surgery. Researchers developed a gene signature, and in tests, the signature identified ...

[email protected] Almac will be exhibiting at Pharma Packaging & Labeling Philadelphia 26 – 27 Feb 2014 and Interphex New York 18 – 20 March 2014. Notes to Editors ...

Currently, Almac’s Audubon facility provides space for 400 pallets in the 2-8°C range while the new facility allows for up to 1600 pallets. Storage for 15 - 25°C products also expanded from 4200 to ...

Almac has announced that it has signed an exclusive global distribution deal with Affymetrix, Inc. enabling them to directly sell Almac’s proprietary Xcel™ array for biomarker discovery, development ...

Almac Sciences has completed an expansion of active pharmaceutical ingredient production in Craigavon, Northern Ireland, that adds continuous-flow manufacturing capabilities. The company also ...

Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors. The company employs over 2,600 individuals and is headquartered in ...

Almac Group, a contract pharmaceutical development and manufacturing organization, plans to invest $93.5 million and add 355 new jobs for the project near Souderton, announced Gov. Tom Wolf on ...

Almac Discovery and Immune Therapy Holdings (ITH), a spin out company from the Karolinska Institute, Stockholm, today announced that they have engaged in a collaboration to develop a novel medical ...

Credit: Almac The pharmaceutical services firm Almac is embarking on a $34 million expansion in the U.S. and Europe that should increase its staff by 9% to about 5,000 by the end of next year.

Pharmaceutical giant Almac, which is based in Craigavon, has reported a turnover of more than £500m for first time. The pharmaceutical development and manufacturing company also reported an ...